Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...
India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...
Divi’s Laboratories came under pressure on Monday following a key negative development around a blockbuster cardiac drug. SEBI-registered analyst Prabhat Mittal said Divi’s made an intraday low of ...
The ever-popular scalp serum and root touch-up are now at a reduced price point, but it won’t last for long. The serum has earned rave reviews from me in particular, with the viral scalp serum also ...
Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback